Mankind Pharma on Wednesday said its consolidated net profit increased 55% to Rs 460 crore for the third quarter ended December 2023.
The company had posted a net profit of Rs 296 crore in the October-December quarter of the last fiscal.
Its revenue from operations rose to Rs 2,607 crore in the period under review from Rs 2,091 crore in the year-ago period, Mankind Pharma said in a statement.
Shares of the company ended 2.79% down at Rs 1,999.55 apiece on the BSE.
Add us to your Preferences
Set as your preferred source on Google
ADVERTISEMENT
RECOMMENDED FOR YOU
Hero MotoCorp Q2 Results: Profit, Revenue Jump 16%, Led By Motorcycle Sales, GST Boost
RVNL Q2 Results: Profit Declines For Second Straight Quarter Despite Revenue Jump
Bharat Forge Q2 Results: Profit Rises 23%; Shares Jump Nearly 4%
Jefferies Keeps Mankind Pharma Among Top Picks Despite Q2 Setback — Check Revised Target Price
POPULAR
1
San Francisco Has Self-Driving Cars, India Has 10-Minute Everything: US-Based Firm's Indian-Origin CEO
2
Crypto Downturn Wipes Out Nearly $1 Billion In Levered Bets
3
November Auto Sales Updates: Hero MotoCorp Exports Sales Up Most; Maruti Suzuki Total Production Rises
4
BMC Elections 2026: Mumbai Civic Body Receives EVMs For Upcoming Polls
5